NNVC
NanoViricides Inc
NYSE MKT: NNVC · HEALTHCARE · BIOTECHNOLOGY
$1.24
+1.64% today
Updated 2026-04-30
Market cap
$26.99M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.49
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
NanoViricides Inc (NNVC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $659545.00 | $662954.00 | $680058.00 | $695911.00 | $699724.00 | $704538.00 | $723325.00 | $747529.00 | $759014.00 | $743805.00 |
| Gross profit | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $-659545.00 | $-662954.00 | $-680058.00 | $-695911.00 | $-699724.00 | $-704538.00 | $-723325.00 | $-747529.00 | $-759014.00 | $-743805.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $899891.00 | $731808.00 | $839237.00 | $1.73M | $3.20M | $4.16M | $4.27M | $4.29M | $5.13M | $3.66M | $5.03M | $5.53M | $4.83M | $5.92M | $4.70M | $6.11M | $5.78M | $6.39M | $5.44M | $5.55M |
| SG&A | — | $2.35M | $1.95M | $1.09M | $1.74M | $2.27M | $1.82M | $2.30M | $3.54M | $3.40M | $3.83M | $4.07M | $4.50M | $2.74M | $3.30M | $2.63M | $2.33M | $2.55M | $3.08M | $4.04M |
| Operating income | $-2.60M | $-3.08M | $-2.79M | $-2.82M | $-4.94M | $-6.43M | $-6.08M | $-6.59M | $-8.67M | $-7.06M | $-8.86M | $-9.60M | $-9.33M | $-8.66M | $-8.00M | $-8.74M | $-8.11M | $-8.94M | $-8.52M | $-9.59M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-2.55M | $-3.03M | $-2.73M | $-2.81M | $-4.65M | $-5.95M | $-5.99M | $-7.56M | $-8.28M | $-6.76M | $-8.20M | $-8.94M | $-8.59M | $-7.96M | $-7.30M | $-8.04M | $-7.38M | $-7.84M | $-7.49M | $-8.72M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-2.60M | $-3.06M | $-2.75M | $-2.82M | $-4.74M | $-6.48M | $-6.21M | $-7.78M | $-8.50M | $-7.06M | $-8.86M | $-9.60M | $-9.27M | $-8.66M | $-8.00M | $-8.74M | $-8.10M | $-8.59M | $-8.24M | $-9.47M |
| Interest expense | $0.00 | $90562.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.09M | $3.66M | $3.82M | $2.47M | $2.13M | $544488.00 | $0.00 | $93670.00 | $85405.00 | $5123.00 | $938.00 | $49808.00 | $149.00M |
| Income tax | $688584.00 | $36051.00 | $-53704.00 | $31.93B | $-195743.00 | $47710.00 | $125458.00 | $1.09M | $3.66M | $3.66M | $2.47M | $2.13M | $1.31M | $-179745.00 | $-48999.00 | $85405.00 | $-6736.00 | $355833.00 | — | — |
| Effective tax rate | -26.5% | -1.2% | 1.9% | 100.0% | 4.0% | -0.7% | -2.1% | -14.0% | -35.1% | 250.2% | -29.9% | -26.0% | -18.0% | 2.1% | 0.4% | -1.0% | 0.1% | -4.3% | 0.0% | 0.0% |
| Net income | $-3.28M | $-3.12M | $-2.74M | $-2.79M | $-4.74M | $-6.48M | $-6.21M | $-8.88M | $-14.11M | $-2.20M | $-10.72M | $-10.30M | $-8.56M | $-8.24M | $-13.45M | $-8.82M | $-8.11M | $-8.59M | $-8.29M | $-9.47M |
| Net income growth (YoY) | — | +5.0% | +12.2% | -1.8% | -70.2% | -36.5% | +4.2% | -43.0% | -58.9% | +84.4% | -387.9% | +3.9% | +16.9% | +3.7% | -63.1% | +34.4% | +8.1% | -5.9% | +3.4% | -14.1% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |